GT Biopharma, Inc. (GTBP)
GT Biopharma Market Cap: 7.126M for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 92.08M |
| Geron Corp. | 826.67M |
| Regeneron Pharmaceuticals, Inc. | 76.34B |
| SELLAS Life Sciences Group, Inc. | 279.90M |
| Xencor, Inc. | 1.224B |
Market Cap Related Metrics
| Price to Book Value | 2.376 |
| Price | 0.67 |
| Earnings Yield | -506.7% |